The pricing anomalies with respect to Lipitor should be sorted out when the 180-day exclusivity period for Ranbaxy’s and WPI’s generics expire in May 2012. Or possibly sooner. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”